23 Jul Vor Biopharma
Robert Ang, CEO
Oct. 10 | 1:45pm | Ecolab Life Sciences Ballroom
Vor Bio’s novel approach in the fight against cancer: engineer treatment-resistant Hematopoietic Stem Cells (eHSCs) that allow new, potentially curative targeted therapy opportunities post-transplant. We aim to protect the healthy cells and expose the cancer.